O'Connor, D., Moorman, A., Wade, R., Hancock, J., Tan, R., Bartram, J., . . . Samarasinghe, S. (2017). Use of Minimal Residual Disease Assessment to Redefine Induction Failure in Pediatric Acute Lymphoblastic Leukemia. American Society of Clinical Oncology.
Chicago Style aipamenaO'Connor, D., et al. Use of Minimal Residual Disease Assessment to Redefine Induction Failure in Pediatric Acute Lymphoblastic Leukemia. American Society of Clinical Oncology, 2017.
MLA aipamenaO'Connor, D., et al. Use of Minimal Residual Disease Assessment to Redefine Induction Failure in Pediatric Acute Lymphoblastic Leukemia. American Society of Clinical Oncology, 2017.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.